BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27267320)

  • 1. lncRNA Up-Regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence.
    Zhang S; Zhong G; He W; Yu H; Huang J; Lin T
    J Urol; 2016 Oct; 196(4):1270-8. PubMed ID: 27267320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer.
    He W; Cai Q; Sun F; Zhong G; Wang P; Liu H; Luo J; Yu H; Huang J; Lin T
    Biochim Biophys Acta; 2013 Oct; 1832(10):1528-37. PubMed ID: 23688781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans.
    Yang F; Zhang L; Huo XS; Yuan JH; Xu D; Yuan SX; Zhu N; Zhou WP; Yang GS; Wang YZ; Shang JL; Gao CF; Zhang FR; Wang F; Sun SH
    Hepatology; 2011 Nov; 54(5):1679-89. PubMed ID: 21769904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12.
    Fan Y; Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y
    Clin Cancer Res; 2014 Mar; 20(6):1531-41. PubMed ID: 24449823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
    Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
    Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMOX1 is an important prognostic indicator of nonmuscle invasive bladder cancer recurrence and progression.
    Yim MS; Ha YS; Kim IY; Yun SJ; Choi YH; Kim WJ
    J Urol; 2011 Feb; 185(2):701-5. PubMed ID: 21168882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma.
    Shang C; Guo Y; Zhang H; Xue YX
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):507-13. PubMed ID: 26781446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer.
    Xue Y; Ma G; Zhang Z; Hua Q; Chu H; Tong N; Yuan L; Qin C; Yin C; Zhang Z; Wang M
    Oncotarget; 2015 Jan; 6(1):484-93. PubMed ID: 25514464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer.
    Chen T; Xie W; Xie L; Sun Y; Zhang Y; Shen Z; Sha N; Xu H; Wu Z; Hu H; Wu C
    Biochem Biophys Res Commun; 2015 Dec; 468(4):666-70. PubMed ID: 26551459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of EZH2, a polycomb group protein, in bladder carcinoma.
    Arisan S; Buyuktuncer ED; Palavan-Unsal N; Caşkurlu T; Cakir OO; Ergenekon E
    Urol Int; 2005; 75(3):252-7. PubMed ID: 16215315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of EZH2 and SUZ12 Regulated by E2F1 Predicts the Disease Progression and Aggressive Characteristics of Bladder Cancer.
    Lee SR; Roh YG; Kim SK; Lee JS; Seol SY; Lee HH; Kim WT; Kim WJ; Heo J; Cha HJ; Kang TH; Chung JW; Chu IS; Leem SH
    Clin Cancer Res; 2015 Dec; 21(23):5391-403. PubMed ID: 26268246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA HEIH suppresses the expression of TP53 through enhancer of zeste homolog 2 in oesophageal squamous cell carcinoma.
    Ding X; Qi C; Min J; Xu Z; Huang K; Tang H
    J Cell Mol Med; 2020 Sep; 24(18):10551-10559. PubMed ID: 32729661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
    Zhan Y; Lin J; Liu Y; Chen M; Chen X; Zhuang C; Liu L; Xu W; Chen Z; He A; Zhang Q; Sun X; Zhao G; Huang W
    J Exp Clin Cancer Res; 2016 May; 35(1):83. PubMed ID: 27206339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.
    Zhan Y; Liu Y; Wang C; Lin J; Chen M; Chen X; Zhuang C; Liu L; Xu W; Zhou Q; Sun X; Zhang Q; Zhao G; Huang W
    Oncotarget; 2016 Mar; 7(13):16038-48. PubMed ID: 26799188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EZH2 polycomb transcriptional repressor expression correlates with methylation of the APAF-1 gene in superficial transitional cell carcinoma of the bladder.
    Hinz S; Kempkensteffen C; Weikert S; Schostak M; Schrader M; Miller K; Christoph F
    Tumour Biol; 2007; 28(3):151-7. PubMed ID: 17541304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
    Shi XM; Teng F
    Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of the long noncoding RNA HOTAIR predicts recurrence in stage Ta/T1 bladder cancer.
    Yan TH; Lu SW; Huang YQ; Que GB; Chen JH; Chen YP; Zhang HB; Liang XL; Jiang JH
    Tumour Biol; 2014 Oct; 35(10):10249-57. PubMed ID: 25030736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
    Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
    Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic inactivation of KLF4 is associated with urothelial cancer progression and early recurrence.
    Li H; Wang J; Xiao W; Xia D; Lang B; Wang T; Guo X; Hu Z; Ye Z; Xu H
    J Urol; 2014 Feb; 191(2):493-501. PubMed ID: 24018236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regularly methylated novel pro-apoptotic genes associated with recurrence in transitional cell carcinoma of the bladder.
    Christoph F; Weikert S; Kempkensteffen C; Krause H; Schostak M; Miller K; Schrader M
    Int J Cancer; 2006 Sep; 119(6):1396-402. PubMed ID: 16642478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.